In areas where visceral leishmaniasis is anthroponotic, asymptomatically infected patients may play a role in transmission. Additionally, the number of asymptomatic patients in a disease-endemic area will also provide information on transmission dynamics. Libo Kemkem and Fogera districts (Amhara State, Ethiopia) are now considered newly established areas to which visceral leishmaniasis is endemic. In selected villages in these districts, we conducted a study to assess the usefulness of different approaches to estimate the asymptomatic infection rate. Of 605 participants, the rK39 immunochromatographic test was able to detect asymptomatic infection in 1.5% (9 of 605), direct agglutination test in 5.3% (32 of 605), and leishmanin skin test in 5.6% (33 of 589); the combined use of serologic methods and leishmanin skin test enabled detecting asymptomatic infection in 10.1% (61 of 605). We conclude that the best option to detect asymptomatic infection in this new visceral leishmaniasis-endemic focus is the combined use of the direct agglutination test and the leishmanin skin test.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335682PMC
http://dx.doi.org/10.4269/ajtmh.2012.11-0196DOI Listing

Publication Analysis

Top Keywords

leishmanin skin
16
skin test
16
asymptomatic infection
16
direct agglutination
12
agglutination test
12
visceral leishmaniasis
12
test
8
test leishmanin
8
detecting asymptomatic
8
amhara state
8

Similar Publications

ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis.

PLoS One

June 2024

Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Laboratório de Soroepidemiologia, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil.

American tegumentary leishmaniasis (ATL) diagnosis is an open question, and the search for a solution is urgent. The available tests that detect the etiological agent of the infection are specific for ATL diagnosis. However, they present disadvantages, such as low sensitivity and the need for invasive procedures to obtain the samples.

View Article and Find Full Text PDF

Chagas Disease and Leishmaniasis, Sympatric Zoonoses Present in Human from Rural Communities of Venezuela.

Acta Parasitol

March 2024

Instituto de Zoología y Ecología Tropical (IZET), Facultad de Ciencias, Universidad Central de Venezuela (UCV), Caracas, Venezuela.

Purpose: Trypanosoma cruzi and Leishmania spp. coexist in several endemic areas, and there are few studies of Chagas disease and leishmaniasis coinfection worldwide; for this reason, the objective of this work was to determine the Chagas disease and leishmaniasis coinfection in several rural communities co-endemic for these diseases.

Methods: A total of 1107 human samples from six co-endemic rural communities of Cojedes state, Venezuela, were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed human and wild rodent infection rates of leishmaniasis in northeast Brazil to understand how transmission occurs in altered environments.
  • Human participants showed significant rates of leishmanin skin test positivity (34.3%-56.3%) and scars indicative of ACL (12.2%-47.5%), with infection probability linked to age and exposure duration.
  • Rodents exhibited high rates of asymptomatic infection and were likely contributing to ongoing human transmission, highlighting the connection between rodents, human habitats, and potential leishmaniasis spread.
View Article and Find Full Text PDF

Background: This study aimed to define immunological markers of exposure to L. major parasites and identify correlates of protection against infection.

Methods: We analyzed a cohort of 790 individuals at risk of developing ZCL living in endemic areas with varying L.

View Article and Find Full Text PDF

The leishmanin skin test was used for almost a century to detect exposure and immunity to Leishmania, the causative agent of leishmaniasis, a major neglected tropical disease. Due to a lack of antigen used for the intradermal injection, the leishmanin skin test is no longer available. As leishmaniasis control programs are advancing and new vaccines are entering clinical trials, it is essential to re-introduce the leishmanin skin test.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!